JR17/00026 AYUDA JOAN RODÉS DRA. TANIA FLEITAS /2017/322)

"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction"

Papaccio, Federica; (...); Castillo, Josefa

Article. 10.1186/s13046-022-02591-z. 2023

• 
• Documentos

Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer.

Tarazona, Noelia; (...); Cervantes, Andres

Article. 10.1136/esmoopen-2020-000847. 2020

• 
• Documentos

In the literature: October 2021.

Gambardella, V; (...); Cervantes, A

News Item. 10.1016/j.esmoop.2021.100285. 2021

• 
• Documentos

Integrative immune transcriptomic classification could improve patient selection for precision immunotherapy in advanced gastroesophageal adenocarcinoma

Segura, MC; (...); Fleitas, TC

Meeting Abstract. 10.1016/j.annonc.2022.09.065. 2022

NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2 -Amplified Gastric Cancer.

Gambardella, V; (...); Cervantes, A

Article. 10.1158/1078-0432.CCR-18-2421. 2019

• 
• Documentos

Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress.

Gambardella, Valentina; (...); Cervantes, Andres

Article. 10.3390/jcm9093049. 2020

• 
• Documentos

Reply to the letter to the editor: adjuvant nivolumab for the management of the pathological residual disease in esophageal or junctional tumors: a word of caution by PK Garg, R. Kumar and P. Dixit

Smyth, E C; (...); Fleitas, T

Letter. 10.1016/j.annonc.2021.05.795. 2021

• 
• Documentos

Towards precision oncology for anti-HER2 blockade in gastroesophageal adenocarcinoma.

Gambardella, V; (...); Cervantes, A

Review. 10.1093/annonc/mdz143. 2019

• 
• Documentos

Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer

Gambardella, V, Fleitas, T, Cervantes, A

Editorial Material. 10.1093/annonc/mdz008. 2019

• 
• Documentos